Navigation Links
Regenerating heart tissue topic of UH lecture Nov. 27
Date:11/14/2012

HOUSTON, Nov. 14, 2012 With chronic heart failure affecting 5.4 million people and 690,000 new cases being diagnosed each year, therapies for reversing disease progression are needed. Developing pharmacological approaches for regenerating and improving function in damaged heart tissue will be the focus of a lecture Nov. 27 at the University of Houston (UH).

Mark Mercola, professor and director of the Muscle Development and Regeneration Program at the Sanford-Burnham Medical Research Institute, will present "Regenerating Damaged Heart Muscle: Using Stem Cells and Systems Biology to Discover Drug Targets." He will be this year's final speaker in a UH lecture series highlighting the impact of science on health and society. The lecture is free and open to the public.

Mercola is known for discovering signaling pathways that control heart formation during embryonic development. These discoveries have provided a mechanistic understanding of how primitive cells in the embryo form heart muscle and are the basis of his current work to regenerate heart muscle cells from embryonic and cardiac stem cells.

He directs a multidisciplinary team of engineers, chemists and stem cell biologists to develop automated, high-throughput techniques to discover small drug-like molecules that direct stem cells to form heart muscle cells that could lead to new classes of drugs to stimulate regeneration of damaged heart muscle. His lab also uses transgenic and surgical models of heart disease to evaluate candidate drug targets and genes involved in stem cell-based creation of new muscle tissue, as well as preservation of heart muscle and function post-injury.

His research is supported by grants from the Heart, Lung and Blood Institute of the National Institutes of Health and the California Institute for Regenerative Medicine.

The Friends of NSM Distinguished Lecture Series, sponsored by the College of Natural Sciences and Mathematics, features leading scientists and physicians addressing breakthroughs in science that will alter the prevention, diagnosis and treatment of diseases, as well as impact the delivery of medical care.

WHO:
Mark Mercola, Ph.D.
Professor and Director, Muscle Development and Regeneration Program
Sanford-Burnham Medical Research Institute

WHAT:
Friends of NSM Distinguished Lecture Series: Science Impacting Health and Society
Lecture: "Regenerating Damaged Heart Muscle: Using Stem Cells and Systems Biology to Discover Drug Targets"

WHEN:
7 8 p.m., Tuesday, Nov. 27

WHERE:
University of Houston
Rockwell Pavilion, second floor of the UH M.D. Anderson Library
Off Calhoun Road, Entrance 1
Map: http://www.friends.nsm.uh.edu/directions


'/>"/>

Contact: Lisa Merkl
lkmerkl@uh.edu
713-743-8192
University of Houston
Source:Eurekalert  

Related biology news :

1. Potential new approach to regenerating skeletal muscle tissue
2. Bone marrow stem cells do not improve short-term recovery after heart attack
3. Losing protein helps heart recover, say Temple scientists
4. Softening arteries, protecting the heart
5. First-ever 3-D stress map of developing embryonic heart sheds light on why defects form
6. Finding triggers of birth defects in an embryo heart
7. Reducing radiation: Heart Institute model shows hope for new standards worldwide
8. Obese moms give birth to heart healthier kids following bariatric surgery
9. Exercise is smart for your heart - and makes you smarter
10. National Heart Centre Singapore develops worlds first human heart cell model
11. Pioneering researcher receives Heart Association Lifetime Achievement Award
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Regenerating heart tissue topic of UH lecture Nov. 27
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:3/31/2016)...   LegacyXChange, Inc. ... LegacyXChange is excited to release its first ... be launched online site for trading 100% guaranteed authentic ... also provide potential shareholders a sense of the value ... industry that is notorious for fraud. The video is ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... MONICA, Calif. , June 23, 2016  The Prostate Cancer Foundation ... pioneer increasingly precise treatments and faster cures for prostate cancer. Members of the ... institutions across 15 countries. Read More About the Class ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample ... the Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. ... said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our capacity ...
(Date:6/23/2016)... 2016 Andrew D ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
Breaking Biology Technology: